奇正藏藥(002287.SZ):產品在墨脫縣和米林縣縣級醫院、藏醫院以及鄉鎮衛生院都已經實現了覆蓋
格隆匯7月29日丨奇正藏藥(002287.SZ)在互動平臺表示,公司一直積極拓展雅下項目區域內相關產品的覆蓋和推廣,擴大公司藏藥產品在本地的覆蓋率。目前公司的核心產品消痛貼膏、青鵬軟膏、白脈軟膏、紅花如意丸等產品在墨脫縣和米林縣縣級醫院、藏醫院以及鄉鎮衛生院都已經實現了覆蓋。未來公司也會積極推廣紅景天口服液(用於高山反應)和十味龍膽花膠囊(呼吸系統用藥)等高原常用藥的覆蓋。公司將深耕細作、保障供應,服務於廣大的工程建設者、本地居民和進藏遊客。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.